GuidelineAnnals of oncology : official journal of the European Society for Medical Oncology2013
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).
Guideline in Annals of oncology : official journal of the European Society for Medical Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02542332 (Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?), which is not on this map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?
Who cites it
21 citing papers in PubMed, 102 citations in OpenAlex.
- Trial
- Lung Cancer Screening Using Low Dose CT Scanning in Germany. Extrapolation of results from the National Lung Screening Trial.Deutsches Arzteblatt international · 2015Trial
- Targeting of low-dose CT screening according to the risk of lung-cancer death.The New England journal of medicine · 2013Trial
- Impact of lung cancer discovery mode on cancer outcomes: data from the KBP-2020-CPHG study.ERJ open research · 2026Article
- Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings.JTO clinical and research reports · 2026Article
- Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009-2022.Cancer reports (Hoboken, N.J.) · 2025Article
- A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules.Genomics, proteomics & bioinformatics · 2025Article
- PET radiomics-based lymphovascular invasion prediction in lung cancer using multiple segmentation and multi-machine learning algorithms.Physical and engineering sciences in medicine · 2024Article
- Lung cancer screening by low-dose CT scan in France: final results of the DEP KP80 study after three rounds.EBioMedicine · 2024Article
- Perceptions and feelings of a French sample regarding lung cancer screening.BMC public health · 2023Article
- Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer.Journal of Cancer · 2023Article
- Confocal laser endomicroscopy to guide sampling of a pure ground-glass opacity.ERJ open research · 2021Article
- Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.BMC cardiovascular disorders · 2019Article
- Article
- Landscape on CT screening for lung cancer in Asia.Lung Cancer (Auckland, N.Z.) · 2019Review
- Do doctors understand the test characteristics of lung cancer screening?Wiener klinische Wochenschrift · 2018Article
- Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations.BMC public health · 2017Article
- Annual or biennial lung cancer CT screening?Journal of thoracic disease · 2016Article
- Lung cancer screening: history, current perspectives, and future directions.Archives of medical science : AMS · 2015Article
- Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.PLoS medicine · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 17 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite advances in cancer therapy, mortality is still high except in early-stage tumors, and screening remains a challenge. The randomized National Lung Screening Trial (NLST), comparing annual low-dose computed tomography (LDCT) and chest X-rays, revealed a 20% decrease in lung-cancer-specific mortality. These results raised numerous questions. The French intergroup for thoracic oncology and the French-speaking oncology group convened an expert group to provide a coherent outlook on screening modalities in France.
methodsA literature review was carried out and transmitted to the expert group, which was divided into three workshops to tackle specific questions, with responses presented in a plenary session. A writing committee drafted this article.
resultsThe multidisciplinary group favored individual screening in France, when carried out as outlined in this article and after informing subjects of the benefits and risks. The target population involves subjects aged 55-74 years, who are smokers or have a 30 pack-year smoking history. Subjects should be informed about the benefits of quitting. Screening should involve LDCT scanning with specific modalities. Criteria for CT positivity and management algorithms for positive examinations are given.
conclusionsIndividual screening requires rigorous assessment and precise research in order to potentially develop a lung-cancer screening policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.